Viikinkaari 5 E (P.O. Box 56)
00014 University of Helsinki
Phone +358-(0)294 1911 (University)
Welcome to the Faculty of Pharmacy of the University of Helsinki!
Pharmacy is a multidisciplinary field of science. It specialises in medicinal treatment and studies drugs, medicines and their development, use and effects mainly from the point of view of natural sciences, health sciences, as well as social sciences.
The Faculty of Pharmacy offers Bachelor's, Master's and postgraduate programmes. The Faculty also provides professional postgraduate education in industrial pharmacy for those with a Bachelor or Master's degree in pharmacy and plays an active part in the continuing education in the field.
The Faculty is also nationally responsible for the Swedish-language Master's programmes in Pharmacy.
Oluwaseun Oyemade to receive a Faculty for the Future grant (16.7.2015)
PhD student Oluwaseun Oyemade from Nigeria has been awarded a Faculty for the Future grant of the Schlumberger Foundation. The grant is intended for the 2015-2016 academic year to study under Professor Marja Airaksinen. More than a thousand applications were submitted and only 155 grants were awarded. Oluwaseun Oyemade's project concentrates on urban Nigerians and their coping with different health problems.
Nanocrystals: more tools for delivering poorly water soluble drugs (16.6.2015)
Nanocrystal technologies have been introduced as advantageous formulation approaches for poorly water soluble molecules. Annika Tuomela studied for her doctoral dissertation both liquid and solid nanocrystal dosage forms and prepared high-quality nanocrystal suspensions using wet milling technique. She also developed an in vivo effective nanocrystal suspension formulation for ocular delivery to treat elevated intraocular pressure.
Professor Arto Urtti nominated to the CRS advisory board (11.6.2015)
CRS (Controlled Release Society) is an international organisation covering the field of controlled release: scientific and technical efforts to regulate the spatial and temporal effects of agents in for example human and animal health as well as non-pharmaceutical areas.
Rheumatoid arthritis: biologic drugs at least as safe and efficient as methotrexate (28.5.2015)
Rheumatoid arthritis is treated with synthetic disease-modifying anti-rheumatic (sDMARDs) and biologic drugs. More than 20% of Finnish patients with rheumatoid arthritis are using biologic drugs based on the inhibition of tumor necrosis factor, with a majority of them in combination therapy with sDMARDs. Kalle Aaltonen found out in his doctoral thesis that the efficacy and safety of biologic drugs are comparable to methotrexate and only few differences between individual agents could be observed.
Rhazya stricta: biotechnological methods developed for alkaloid production (26.5.2015)
Amir Akhgari developed the first simple and efficient gene transfer method for Rhazya stricta, a traditional medicinal plant in the Middle East and South Asia. Rhazya stricta produces a large number of terpenoid indole alkaloids, and some of them have important pharmacological properties. He also established new analytical methods which made possible a comprehensive investigation of the alkaloids.
Best Thesis Award to Dongfei Liu (22.4.2015)
Dr Dongfei Liu has been awarded with the Best Thesis Award of the University of Helsinki. In his doctoral thesis, Porous Silicon-Based Multicomposites for Controlled Drug Delivery, he developed a method for manufacturing medical composite nanomaterials with an ability to control the exact contents of the composites.
Excellence in Research Award by the ASGCT to Mari Hirvinen (15.4.2015)
Mari Hirvinen has been awarded an Excellence in Research Award by the American Society of Gene & Cell Therapy (ASGCT). Mari got the award because of her excellent abstract Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice, which was chosen as one of the top six amongst thousands of abstracts submitted for the ASGCT Annual Meeting.
Creating homogenous tunable nanoparticles (8.4.2015)
A microfluidic platform created by Dr Santos' and Dr Sikanen's groups produces homogeneous nanoparticles with tunable properties with the helpo of a high throughput synthesis.
Unique technique helps building innovative nanomedicines for cancer therapy (16.3.2015)
A new multi-stage nanocomposite for cancer therapy has been produced by nanoprecipitation.
New information on Parkinson's disease and GDNF (4.3.2015)
Recent Finnish study overturns results from seven years ago. Neurotrophic factor GDNF is not needed by the midbrain dopamine system.
Testing the possibilities of porous silicon nanoparticles for cancer therapy (24.2.2015)
Anticancer drugs kill the rapidly dividing cancer cells, but they can also cause severe damage to healthy tissues. Nanocarriers can be modified for targeted drug delivery applications. Chang-Fang Wang modified the surface structures of the porous silicon nanoparticles in different ways to enhance their uptake in tumour cells.
Porous silicon nanoparticles: surface modification has significant effects (11.2.2015)
Mohammad-Ali Shabhazi's doctoral dissertation points out that surface structure can affect the toxicological profiles the, cellular interactions and the therapeutic effects of the porous silicon nanoparticles.
Apply now for the right to pursue a doctoral degree! (4.2.2015)
Application period is 4–25 February 2015. The applications are sent through an electric application portal Aava.
Memorandum of Understanding signed with the Guangdong Pharmaceutical University, China (23.1.2015)
Joint research topics, researcher and teacher exchange and educational collaboration have been discussed with the GDPU in China. More detailed mutual agreements on different activities are still needed.
An Iranian research prize for Mohammad-Ali Shahbazi (16.1.2015)
Mohammad-Ali Shahbazi has received prize of the Best Young Researcher of Pharmaceutical Sciences in The 20th Razi Medical Sciences Research Festival, Iran.
World-class research in pharmacy at the University of Helsinki (3.12.2014)
Research in pharmacy was rated highly in the Academy of Finland Tieteen tila (The State of Science) report for 2014. Successful recruitments and new technology provide opportunities to further improve the University's international cooperation and funding base.
Reward for exceptionally productive research work for Hélder Santos (6.11.2014)
The Dean of the Faculty of Pharmacy has decided to reward Dr. Hélder Santos for his exceptionally productive research work in 2014. Dr. Santos has published 29 articles in peer rewied journals by the end of October.
€ 283.000 grant for a molecular nanomachine for Hongbo Zhang (28.10.2014)
Dr. Hongbo Zhang has been awarded a Jane and Aatos Erkko Foundation grant to build a porous silicon-based multifunctional nanoshuttle for cancer therapy. The grant is for three years.
Vincenzo Cerullo awarded the Outstanding Young Investigator Award in Gene and Cell Therapy (27.10.2014)
Assistant professor Vincenzo Cerullo has been awarded the Outstanding Young Investigator Award in Gene and Cell Therapy 2014 by ESGCT, European Society of Gene and Cell Therapy. The € 1,000 award is given to a young investigator from PhD through to 9 years post doc.
A PhD position in Supramolecular Drug Delivery (21.10.2014)
A PhD position in Supramolecular Drug Delivery is available at the Division of Pharmaceutical Chemistry and Technology, University of Helsinki, together with the Biohybrid Materials group at Aalto University.
For analyzing steroids, vitamin D and oxysterols, Linda Ahonen has developed new methods based on mass spectrometry. These compounds, members of the lipid group, are important in the function of the human body. In many cases, the monitoring of these analytes can be of high value.
"With some additional development, some of the presented methods could be implemented for example in routine laboratories", says Linda Ahonen in her doctoral thesis.
Leena-Stiina Kontturi found out in her doctoral dissertation that hydrogel made of cross-linked collagen and interpenetrating hyaluronic acid is promising in capsulating cells producing anti-angiogenic protein for the treatment of retinal neovascularization. She also developed a cell-encapsulating device and a PK/PD model that could be used to predict therapeutic responses after intravitreal anti-angiogenic drug delivery.
There is a huge interest for creating multicomposites that could carry several different kinds of therapeutic molecules simultaneously for controlled drug delivery. Dongfei Liu's doctoral dissertation shows how a promising porous silicon-based multicomposite carrier was designed, prepared and characterized. Multicomposite systems represent a promising platform for future targeted combination therapies.
New organotypic liver cell cultures are needed to predict the metabolism, excretion, and safety of chemical compounds. Melina Malinen has in her doctoral dissertation developed 3D culture methods for licer cells. In 3D structure, the cells can function more normally than in nowadays more typical 2D cultures.
Professor Heikki Ruskoaho has been appointed a chairman of the Board of the Academy of Finland. The term lasts till the end of 2018.
Finnish research into ocular medication: FDA funding secured for the first time (27.8.2014)
Research into ocular medication carried out in Finland has secured a significant 250 000 dollar funding from the US Food and Drug Administration, FDA, which oversees the use of drugs and drug approval.
University of Helsinki
- University of Helsinki in brief
- Science and Research
- Services and cooperation
- Studying & How to apply?
- Social interaction
- International affairs & International Staff Services
Living in Finland
- Suomi.fi - information on public services
- Infobank - information in 15 languages
- Virtual Finland
- HERA Promotianal Video